{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:00:48Z","timestamp":1790456448890,"version":"4.1.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000854","name":"Human Frontier Science Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000854","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18H02627"],"award-info":[{"award-number":["18H02627"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K16246"],"award-info":[{"award-number":["18K16246"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19KK0199"],"award-info":[{"award-number":["19KK0199"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21H04798"],"award-info":[{"award-number":["21H04798"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K08565"],"award-info":[{"award-number":["21K08565"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS103940"],"award-info":[{"award-number":["R01NS103940"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32GM007752"],"award-info":[{"award-number":["T32GM007752"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005865","name":"Mochida Memorial Foundation for Medical and Pharmaceutical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008880","name":"Kanae Foundation for the Promotion of Medical Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007911","name":"University of California, San Diego","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007911","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.celrep.2023.113545","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T13:33:05Z","timestamp":1701955985000},"page":"113545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["FTY720 requires vitamin B12-TCN2-CD320 signaling in astrocytes to reduce disease in an animal model of multiple sclerosis"],"prefix":"10.1016","volume":"42","author":[{"given":"Deepa","family":"Jonnalagadda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7462-3006","authenticated-orcid":false,"given":"Yasuyuki","family":"Kihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aran","family":"Groves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clayton","family":"Ellington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon-Cheol","family":"Lee-Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Furihata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiko","family":"Yokomizo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward V.","family":"Quadros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerold","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2023.113545_bib1","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","article-title":"Multiple sclerosis","volume":"343","author":"Noseworthy","year":"2000","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2023.113545_bib2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12974-014-0201-8","article-title":"T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases","volume":"11","author":"Gonz\u00e1lez","year":"2014","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.celrep.2023.113545_bib3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa1601277","article-title":"Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis","volume":"376","author":"Hauser","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2023.113545_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jns.2005.03.009","article-title":"Vitamin B12, demyelination, remyelination and repair in multiple sclerosis","volume":"233","author":"Miller","year":"2005","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.celrep.2023.113545_bib5","first-page":"286","article-title":"Vitamin B(12) Deficiency and Multiple Sclerosis; Is there Any Association?","volume":"3","author":"Najafi","year":"2012","journal-title":"Int. J. Prev. Med."},{"key":"10.1016\/j.celrep.2023.113545_bib6","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.biochi.2012.11.004","article-title":"Vitamin B12 absorption: mammalian physiology and acquired and inherited disorders","volume":"95","author":"Kozyraki","year":"2013","journal-title":"Biochimie"},{"key":"10.1016\/j.celrep.2023.113545_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12100","article-title":"Structural basis of transcobalamin recognition by human CD320 receptor","volume":"7","author":"Alam","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2023.113545_bib8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s40265-020-01431-8","article-title":"Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects","volume":"81","author":"Chun","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.celrep.2023.113545_bib9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev-pharmtox-010818-021358","article-title":"Fingolimod: Lessons Learned and New Opportunities for Treating Multiple Sclerosis and Other Disorders","volume":"59","author":"Chun","year":"2019","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.celrep.2023.113545_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108432","article-title":"Molecular and neuroimmune pharmacology of S1P receptor modulators and other disease-modifying therapies for multiple sclerosis","volume":"246","author":"Kihara","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.celrep.2023.113545_bib11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/978-3-030-50621-6_10","article-title":"Druggable Lipid GPCRs: Past, Present, and Prospects","volume":"1274","author":"Mizuno","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.celrep.2023.113545_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/WNF.0b013e3181cbf825","article-title":"Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis","volume":"33","author":"Chun","year":"2010","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.celrep.2023.113545_bib13","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ana.22426","article-title":"Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis","volume":"69","author":"Cohen","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.celrep.2023.113545_bib14","doi-asserted-by":"crossref","first-page":"21453","DOI":"10.1074\/jbc.C200176200","article-title":"The immune modulator FTY720 targets sphingosine 1-phosphate receptors","volume":"277","author":"Brinkmann","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2023.113545_bib15","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1111\/bph.12678","article-title":"Lysophospholipid receptor nomenclature review: IUPHAR Review 8","volume":"171","author":"Kihara","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.celrep.2023.113545_bib16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.yexcr.2014.11.020","article-title":"Lysophospholipid receptors in drug discovery","volume":"333","author":"Kihara","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.celrep.2023.113545_bib17","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1126\/science.1070238","article-title":"Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists","volume":"296","author":"Mandala","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.celrep.2023.113545_bib18","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1126\/science.1208248","article-title":"GRK2-dependent S1PR1 desensitization is required for lymphocytes to overcome their attraction to blood","volume":"333","author":"Arnon","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.celrep.2023.113545_bib19","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature02284","article-title":"Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1","volume":"427","author":"Matloubian","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2023.113545_bib20","first-page":"213","article-title":"A mechanistically novel, first oral therapy for multiple sclerosis: the development of fingolimod (FTY720, Gilenya)","volume":"12","author":"Chun","year":"2011","journal-title":"Discov. Med."},{"key":"10.1016\/j.celrep.2023.113545_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jns.2013.02.011","article-title":"Fingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy","volume":"328","author":"Groves","year":"2013","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.celrep.2023.113545_bib22","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1212\/WNL.0b013e31820d9507","article-title":"The neurobiology of sphingosine 1-phosphate signaling and sphingosine 1-phosphate receptor modulators","volume":"76","author":"Soliven","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.celrep.2023.113545_bib23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0014-5793(02)03404-X","article-title":"Embryonic brain expression analysis of lysophospholipid receptor genes suggests roles for s1p(1) in neurogenesis and s1p(1-3) in angiogenesis","volume":"531","author":"McGiffert","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.celrep.2023.113545_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0378-1119(98)00589-7","article-title":"Comparative analysis of three murine G-protein coupled receptors activated by sphingosine-1-phosphate","volume":"227","author":"Zhang","year":"1999","journal-title":"Gene"},{"key":"10.1016\/j.celrep.2023.113545_bib25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1615\/CritRevNeurobiol.v13.i2.20","article-title":"Lysophospholipid receptors: implications for neural signaling","volume":"13","author":"Chun","year":"1999","journal-title":"Crit. Rev. Neurobiol."},{"key":"10.1016\/j.celrep.2023.113545_bib26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1749-6632.2000.tb06543.x","article-title":"Neurobiology of receptor-mediated lysophospholipid signaling. From the first lysophospholipid receptor to roles in nervous system function and development","volume":"905","author":"Chun","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.celrep.2023.113545_bib27","doi-asserted-by":"crossref","first-page":"33697","DOI":"10.1074\/jbc.M104441200","article-title":"Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LP(B3)\/EDG-3","volume":"276","author":"Ishii","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2023.113545_bib28","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1124\/jpet.107.127183","article-title":"Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis","volume":"323","author":"Foster","year":"2007","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.celrep.2023.113545_bib29","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1073\/pnas.1014154108","article-title":"FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation","volume":"108","author":"Choi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.celrep.2023.113545_bib30","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0239-18.2018","article-title":"A Functionally Defined In\u00a0Vivo Astrocyte Population Identified by c-Fos Activation in a Mouse Model of Multiple Sclerosis Modulated by S1P Signaling: Immediate-Early Astrocytes (ieAstrocytes)","volume":"5","author":"Groves","year":"2018","journal-title":"eNeuro"},{"key":"10.1016\/j.celrep.2023.113545_bib31","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMoa052643","article-title":"Oral fingolimod (FTY720) for relapsing multiple sclerosis","volume":"355","author":"Kappos","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2023.113545_bib32","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1177\/1352458512473190","article-title":"Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes","volume":"19","author":"Vidal-Jordana","year":"2013","journal-title":"Mult. Scler."},{"key":"10.1016\/j.celrep.2023.113545_bib33","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1126\/science.1149967","article-title":"Spine-type-specific recruitment of newly synthesized AMPA receptors with learning","volume":"319","author":"Matsuo","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.celrep.2023.113545_bib34","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.aaf1204","article-title":"Neuronal subtypes and diversity revealed by single-nucleus RNA sequencing of the human brain","volume":"352","author":"Lake","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.celrep.2023.113545_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.918041","article-title":"Single-Nucleus RNA-seq of Normal-Appearing Brain Regions in Relapsing-Remitting vs. Secondary Progressive Multiple Sclerosis: Implications for the Efficacy of Fingolimod","volume":"16","author":"Kihara","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.celrep.2023.113545_bib38","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1242\/dev.077214","article-title":"Regulated temporal-spatial astrocyte precursor cell proliferation involves BRAF signalling in mammalian spinal cord","volume":"139","author":"Tien","year":"2012","journal-title":"Development"},{"key":"10.1016\/j.celrep.2023.113545_bib39","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2023.113545_bib36","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","article-title":"ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks","volume":"25","author":"Bindea","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2023.113545_bib37","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1038\/nprot.2007.324","article-title":"Integration of biological networks and gene expression data using Cytoscape","volume":"2","author":"Cline","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.celrep.2023.113545_bib40","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12859-017-1559-2","article-title":"Reactome pathway analysis: a high-performance in-memory approach","volume":"18","author":"Fabregat","year":"2017","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.celrep.2023.113545_bib41","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nm.4106","article-title":"Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor","volume":"22","author":"Rothhammer","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2023.113545_bib42","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.biochi.2013.02.004","article-title":"Cellular uptake of cobalamin: transcobalamin and the TCblR\/CD320 receptor","volume":"95","author":"Quadros","year":"2013","journal-title":"Biochimie"},{"key":"10.1016\/j.celrep.2023.113545_bib43","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1096\/fj.12-219055","article-title":"The transcobalamin receptor knockout mouse: a model for vitamin B12 deficiency in the central nervous system","volume":"27","author":"Lai","year":"2013","journal-title":"Faseb. J."},{"key":"10.1016\/j.celrep.2023.113545_bib44","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1084\/jem.20101974","article-title":"Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice","volume":"209","author":"Han","year":"2012","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2023.113545_bib45","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2023.113545_bib46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00401-015-1418-z","article-title":"Induction of endogenous Type I interferon within the central nervous system plays a protective role in experimental autoimmune encephalomyelitis","volume":"130","author":"Khorooshi","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.celrep.2023.113545_bib47","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nchembio.547","article-title":"Actions of a picomolar short-acting S1P(1) agonist in S1P(1)-eGFP knock-in mice","volume":"7","author":"Cahalan","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.celrep.2023.113545_bib48","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1007\/s11064-017-2280-2","article-title":"Sphingosine Toxicity in EAE and MS: Evidence for Ceramide Generation via Serine-Palmitoyltransferase Activation","volume":"42","author":"Miller","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.celrep.2023.113545_bib49","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrgastro.2012.76","article-title":"Vitamin B12 transport from food to the body's cells[mdash]a sophisticated, multistep pathway","volume":"9","author":"Nielsen","year":"2012","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.celrep.2023.113545_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnut.2016.00001","article-title":"Severe but Not Moderate Vitamin B12 Deficiency Impairs Lipid Profile, Induces Adiposity, and Leads to Adverse Gestational Outcome in Female C57BL\/6 Mice","volume":"3","author":"Ghosh","year":"2016","journal-title":"Front. Nutr."},{"key":"10.1016\/j.celrep.2023.113545_bib51","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40478-015-0192-4","article-title":"IFNbeta secreted by microglia mediates clearance of myelin debris in CNS autoimmunity","volume":"3","author":"Kocur","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.celrep.2023.113545_bib52","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1194\/jlr.D089938","article-title":"Lysophospholipid G protein-coupled receptor binding parameters as determined by backscattering interferometry","volume":"60","author":"Mizuno","year":"2019","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.celrep.2023.113545_bib53","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1194\/jlr.D120000880","article-title":"Unlabeled lysophosphatidic acid receptor binding in free solution as determined by a compensated interferometric reader","volume":"61","author":"Ray","year":"2020","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.celrep.2023.113545_bib54","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/jnc.13358","article-title":"Establishment and characterization of a new conditionally immortalized human astrocyte cell line","volume":"136","author":"Furihata","year":"2016","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.celrep.2023.113545_bib55","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3168\/jds.S0022-0302(79)83312-3","article-title":"Vitamin B12 binding proteins in bovine serum","volume":"62","author":"Polak","year":"1979","journal-title":"J.\u00a0Dairy Sci."},{"key":"10.1016\/j.celrep.2023.113545_bib56","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1074\/jbc.M110.171116","article-title":"The sphingosine 1-phosphate transporter, SPNS2, functions as a transporter of the phosphorylated form of the immunomodulating agent FTY720","volume":"286","author":"Hisano","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2023.113545_bib57","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/nn2004","article-title":"Astrocyte metabolism and signaling during brain ischemia","volume":"10","author":"Rossi","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.celrep.2023.113545_bib58","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.gene.2010.07.004","article-title":"Characterization of the promoter region of TCblR\/CD320 gene, the receptor for cellular uptake of transcobalamin-bound cobalamin","volume":"466","author":"Jiang","year":"2010","journal-title":"Gene"},{"key":"10.1016\/j.celrep.2023.113545_bib59","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/glia.21021","article-title":"Sphingosine 1-phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions","volume":"58","author":"Van Doorn","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.celrep.2023.113545_bib60","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neulet.2010.04.052","article-title":"Intrathecal increase of sphingosine 1-phosphate at early stage multiple sclerosis","volume":"477","author":"Ku\u0142akowska","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.celrep.2023.113545_bib61","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-3-030-50621-6_6","article-title":"Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities","volume":"1274","author":"Blaho","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.celrep.2023.113545_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2016.e00219","article-title":"Sphingosine-1-phosphate in the lymphatic fluid determined by novel methods","volume":"2","author":"Nagahashi","year":"2016","journal-title":"Heliyon"},{"key":"10.1016\/j.celrep.2023.113545_bib63","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nmeth.1607","article-title":"A roadmap to generate renewable protein binders to the human proteome","volume":"8","author":"Colwill","year":"2011","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2023.113545_bib64","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(15)01314-8","article-title":"Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"387","author":"Lublin","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.celrep.2023.113545_bib65","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s40263-017-0415-2","article-title":"Effect of Fingolimod on Brain Volume Loss in Patients with Multiple Sclerosis","volume":"31","author":"De Stefano","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.celrep.2023.113545_bib66","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jns.2017.10.019","article-title":"A two-year study using cerebral gray matter volume to assess the response to fingolimod therapy in multiple sclerosis","volume":"383","author":"Yousuf","year":"2017","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.celrep.2023.113545_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177156","article-title":"Behavioral alterations are associated with vitamin B12 deficiency in the transcobalamin receptor\/CD320 KO mouse","volume":"12","author":"Arora","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2023.113545_bib68","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s12603-017-0979-z","article-title":"High Serum Folate Is Associated with Brain Atrophy in Older Diabetic People with Vitamin B12 Deficiency","volume":"21","author":"Deng","year":"2017","journal-title":"J.\u00a0Nutr. Health Aging"},{"key":"10.1016\/j.celrep.2023.113545_bib69","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/WCO.0000000000000202","article-title":"Established disease-modifying treatments in relapsing-remitting multiple sclerosis","volume":"28","author":"Oh","year":"2015","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.celrep.2023.113545_bib70","first-page":"iii3","article-title":"History of modern multiple sclerosis therapy","volume":"252","author":"Lublin","year":"2005","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.celrep.2023.113545_bib71","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.4049\/jimmunol.170.9.4776","article-title":"IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis","volume":"170","author":"Teige","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2023.113545_bib72","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0165-5728(02)00182-0","article-title":"Low expression of interferon-stimulated genes in active multiple sclerosis is linked to subnormal phosphorylation of STAT1","volume":"129","author":"Feng","year":"2002","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.celrep.2023.113545_bib73","doi-asserted-by":"crossref","first-page":"e622","DOI":"10.1212\/NXI.0000000000000622","article-title":"Vitamin D enhances responses to interferon-beta in MS","volume":"6","author":"Feng","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.celrep.2023.113545_bib74","first-page":"75","article-title":"Identifying responders and nonresponders to interferon therapy in multiple sclerosis","volume":"4","author":"Prosperini","year":"2014","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"key":"10.1016\/j.celrep.2023.113545_bib75","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.4049\/jimmunol.172.10.6418","article-title":"Attenuation of experimental autoimmune encephalomyelitis and nonimmune demyelination by IFN-beta plus vitamin B12: treatment to modify notch-1\/sonic hedgehog balance","volume":"172","author":"Mastronardi","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2023.113545_bib76","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1096\/fj.15-275180","article-title":"Sphingosine-1-phosphate inhibits IL-1-induced expression of C-C motif ligand 5 via c-Fos-dependent suppression of IFN-beta amplification loop","volume":"29","author":"Yester","year":"2015","journal-title":"FASEB J"},{"key":"10.1016\/j.celrep.2023.113545_bib77","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1073\/pnas.1525356113","article-title":"S1PR1-mediated IFNAR1 degradation modulates plasmacytoid dendritic cell interferon-alpha autoamplification","volume":"113","author":"Teijaro","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.celrep.2023.113545_bib78","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/jnr.24075","article-title":"Astrocyte dysfunction in Alzheimer disease","volume":"95","author":"Acosta","year":"2017","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.celrep.2023.113545_bib79","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/mp.2016.90","article-title":"Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review","volume":"21","author":"Tr\u00e9panier","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.celrep.2023.113545_bib80","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fnbeh.2011.00028","article-title":"Characterization of NMDAR-Independent Learning in the Hippocampus","volume":"5","author":"Tayler","year":"2011","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.celrep.2023.113545_bib81","doi-asserted-by":"crossref","first-page":"21807","DOI":"10.1073\/pnas.0906891106","article-title":"Targeted lipidomics reveals mPGES-1-PGE2 as a therapeutic target for multiple sclerosis","volume":"106","author":"Kihara","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.celrep.2023.113545_bib82","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1084\/jem.20050660","article-title":"Dual phase regulation of experimental allergic encephalomyelitis by platelet-activating factor","volume":"202","author":"Kihara","year":"2005","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2023.113545_bib83","series-title":"Current Protocols in Cell Biology","article-title":"Isolation of Nuclei and Nuclear Membranes From Animal Tissues","author":"Graham","year":"2001"},{"key":"10.1016\/j.celrep.2023.113545_bib84","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nbt.3269","article-title":"Analysis of intronic and exonic reads in RNA-seq data characterizes transcriptional and post-transcriptional regulation","volume":"33","author":"Gaidatzis","year":"2015","journal-title":"Nat Biotech"},{"key":"10.1016\/j.celrep.2023.113545_bib85","doi-asserted-by":"crossref","first-page":"19802","DOI":"10.1073\/pnas.1319700110","article-title":"RNA-sequencing from single nuclei","volume":"110","author":"Grindberg","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.celrep.2023.113545_bib86","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat Meth"},{"key":"10.1016\/j.celrep.2023.113545_bib87","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.12688\/f1000research.7563.1","article-title":"Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences","volume":"4","author":"Soneson","year":"2015","journal-title":"F1000Res."},{"key":"10.1016\/j.celrep.2023.113545_bib88","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.celrep.2023.113545_bib89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6","article-title":"Automated docking of flexible ligands: applications of AutoDock","volume":"9","author":"Goodsell","year":"1996","journal-title":"J.\u00a0Mol. Recognit."},{"key":"10.1016\/j.celrep.2023.113545_bib90","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF00124499","article-title":"Distributed automated docking of flexible ligands to proteins: parallel applications of AutoDock 2.4","volume":"10","author":"Morris","year":"1996","journal-title":"J.\u00a0Comput. Aided Mol. Des."},{"key":"10.1016\/j.celrep.2023.113545_bib91","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J.\u00a0Comput. Chem."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124723015577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124723015577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:38:11Z","timestamp":1790455091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124723015577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":91,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S2211124723015577"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2023.113545","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.01.10.475450","asserted-by":"object"}]},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FTY720 requires vitamin B12-TCN2-CD320 signaling in astrocytes to reduce disease in an animal model of multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2023.113545","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"113545"}}